Constantine Davides

Q: What is Constantine Davides's success rate?

Constantine Davides currently has a success rate of 91.77454156934822.

Q: What is the average return of Constantine Davides's calls?

Their stock ratings have generated an average return of 13.468369112575571.

Citizens | Healthcare

Constantine Davides is an analyst from Citizens specializing in the Healthcare sector. Ranked #1567 out of 4525 analysts, they have issued 33 stock ratings with a success rate of 91.77% and an average return of 13.47%.

Constantine Davides has a well-established track record, with 33 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 91.77% and an average return of 13.47%, underscoring their expertise and ability to identify winning opportunities for investors.

#1567

Out of 4525

Total Ratings

+91.77%

Success Rate

+13.47%

Average Return

Recent Ratings Analysis

PGNY

Buy

Jan 20, 2026

Target

$30.00

Current

$25.38

Performance

0.00%

Constantine Davides rated PGNY as Market Outperform on Jan 20, 2026, setting a price target of 30. Shares have remained stable near 25.38, leaving the 30 target still in play.

OPCH

Buy

Jan 13, 2026

Target

$38.00

Current

$35.79

Performance

2.99%

On Jan 13, 2026, OPCH was given a Market Outperform rating by Constantine Davides, with a target price of 38. The stock traded sideways with a 2.99% move, keeping the bullish thesis unresolved.

EVH

Buy

Jan 06, 2026

Target

$11.00

Current

$3.94

Performance

-1.99%

EVH received a Market Outperform rating from Constantine Davides on Jan 06, 2026, aiming for 11. Price action was muted, as shares hovered around 3.94 despite the bullish outlook.

AMN

Buy

Dec 19, 2025

Target

$24.00

Current

$18.72

Performance

16.71%

On Dec 19, 2025, Constantine Davides published a Market Outperform outlook on AMN, with a target of 24. Shares gained 16.71%, underscoring the accuracy of the bullish outlook toward 24.

HQY

Buy

Dec 04, 2025

Target

$122.00

Current

$84.00

Performance

-12.20%

Constantine Davides on Dec 04, 2025 assigned HQY a Market Outperform rating, with a price target of 122. The call has struggled to gain traction, with shares losing 12.20%.

PRVA

Buy

Nov 07, 2025

Target

$31.00

Current

$23.21

Performance

-0.94%

On Nov 07, 2025, Constantine Davides reaffirmed PRVA with a Market Outperform rating, targeting 31. Market indecision has kept the 31 target in a holding pattern.

OPRX

Buy

Nov 07, 2025

Target

$24.00

Current

$11.94

Performance

-23.71%

OPRX was rated Market Outperform by Constantine Davides on Nov 07, 2025, with a price objective of 24. This case shows how bullish projections can fail, with the stock now below 11.94.

WAY

Buy

Sep 18, 2025

Target

$48.00

Current

$29.74

Performance

-22.91%

On Sep 18, 2025, Constantine Davides initiated coverage on WAY with a Market Outperform rating and target of 48. The Buy call has yet to be validated as shares remain 18.26 away from the target.

ADUS

Buy

Jul 16, 2025

Target

$150.00

Current

$108.67

Performance

0.21%

Constantine Davides issued a Market Outperform recommendation for ADUS on Jul 16, 2025, price target set at 150. The target of 150 remains in play, though confirmation will depend on future moves.

SLP

Hold

Jun 18, 2025

Target

$0.00

Current

$20.26

Performance

12.06%

On Jun 18, 2025, SLP was evaluated by Constantine Davides, who gave a Market Perform rating and target of null. Investors who stayed in despite the Hold saw upside of 12.06%.

AMT

Buy

Feb 26, 2025

Target

$248.00

Current

$177.75

Performance

-11.45%

Constantine Davides rated AMT as Market Outperform on Feb 26, 2025, setting a price target of 248. The stock has underperformed, dropping 11.45% despite the bullish target of 248.

AXGN

Buy

Feb 26, 2025

Target

$26.00

Current

$31.87

Performance

63.77%

On Feb 26, 2025, AXGN was given a Market Outperform rating by Constantine Davides, with a target price of 26. The stock rallied 63.77% after the rating, narrowing the gap to the target of 26 and validating the bullish stance.

AGL

Hold

Feb 26, 2025

Target

$0.00

Current

$0.98

Performance

-70.93%

AGL received a Market Perform rating from Constantine Davides on Feb 26, 2025, aiming for null. The Hold stance proved prudent, with the market softening by 70.93%.

CCRN

Hold

Feb 06, 2025

Target

$0.00

Current

$8.75

Performance

-51.92%

On Feb 06, 2025, Constantine Davides published a Market Perform outlook on CCRN, with a target of null. Weakness in the stock, now at 8.75, supported the conservative rating.

HSTM

Hold

Feb 06, 2025

Target

$0.00

Current

$21.31

Performance

-35.52%

Constantine Davides on Feb 06, 2025 assigned HSTM a Market Perform rating, with a price target of null. The call successfully avoided chasing as shares lost 35.52%.

USPH

Buy

Dec 16, 2024

Target

$113.00

Current

$85.11

Performance

-10.94%

On Dec 16, 2024, Constantine Davides reaffirmed USPH with a Market Outperform rating, targeting 113. Shares slid 10.94% despite the recommendation, highlighting downside risks.

CERT

Hold

Jul 10, 2024

Target

$0.00

Current

$9.49

Performance

-31.63%

CERT was rated Market Perform by Constantine Davides on Jul 10, 2024, with a price objective of null. Investors who stayed cautious avoided some of the 31.63% decline.

Frequency Asked Questions

Who is Constantine Davides?

Constantine Davides is an analyst from Citizens specializing in the Healthcare sector.

What is Constantine Davides's success rate?

Constantine Davides currently has a success rate of +91.77%.

How many ratings has Constantine Davides issued?

Constantine Davides has issued 33 stock ratings so far.

What is the average return of Constantine Davides's calls?

Their stock ratings have generated an average return of +13.47%.

What is Constantine Davides's ranking?

Constantine Davides is ranked #1567 out of 4525 analysts.

What types of ratings does Constantine Davides give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Constantine Davides?

You can follow Constantine Davides by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Constantine Davides?

Their latest rating was a Buy on PGNY issued on 2026-01-20.